Lefaucheur et al, 2017. Clinical Neurophysiology.
- Evidence-based review of the us of Transcranial direct current stimulation (tDCS) in various disorders, concluding in a number of guidelines and recommendations of use.
- Studies reviewed on Parkinson’s disease, other movement disorders, motor stroke, post-stroke aphasia, multiple sclerosis, epilepsy, consciousness disorders, Alzheimer’s disease, tinnitus, depression, schizophrenia, and craving/addiction.
- Level B recommendation (probable efficacy) was recommended for 1. anodal tDCS of the left dorsolateral prefrontal cortex (DLPFC) for Depression, 2. anodal tDCS of the left primary motor cortex (M1) for fibromyalgia, and 3. anodal tDCS of the right DLPFC for addiction/craving.
- Level C recommendation (possible efficacy) was recommended for 1. anodal tDCS of the left M1 (or contralateral to pain side) for chronic lower limb neuropathic pain.